Pfizer Recognizes “Dark Side” Of Scale In R&D; No Sales Force Cuts Planned

Pfizer relies on competition among research teams to help ensure that its vast R&D resources do not diminish the entrepreneurial spirit within the organization, CFO David Shedlarz told the Merrill Lynch pharmaceutical and biotechnology conference Feb. 5 in New York City